
Sensus Healthcare SRTS
$ 4.84
-1.03%
Quarterly report 2025-Q3
added 11-12-2025
Sensus Healthcare Total Assets 2011-2026 | SRTS
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Sensus Healthcare
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62.2 M | 53.7 M | 56.7 M | 32.2 M | 28 M | 36.9 M | 33.3 M | 18.8 M | 18.9 M | 9.64 M | 6.94 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 62.2 M | 6.94 M | 32.5 M |
Quarterly Total Assets Sensus Healthcare
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 58.3 M | 58.9 M | 60.2 M | 62.2 M | 59.9 M | 58.2 M | - | 53.7 M | 50.5 M | 52 M | 53.4 M | 56.7 M | 54.8 M | 56.3 M | 53.9 M | 32.2 M | 25.6 M | 26.4 M | 26.5 M | 28 M | 28 M | 28 M | 28 M | 36.9 M | 36.9 M | 36.9 M | 36.9 M | 33.3 M | 33.3 M | 33.3 M | 33.3 M | 18.8 M | 18.8 M | 18.8 M | 18.8 M | 18.9 M | 18.9 M | 18.9 M | 18.9 M | 9.64 M | 9.64 M | 9.64 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 62.2 M | 9.64 M | 35.9 M |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | ||
|
Cognyte Software Ltd.
CGNT
|
498 M | $ 7.25 | -8.17 % | $ 521 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B | ||
|
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | ||
|
Acutus Medical
AFIB
|
54 M | - | -26.83 % | $ 2.62 M | ||
|
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | ||
|
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | ||
|
Aziyo Biologics
AZYO
|
43.4 M | - | 1.37 % | $ 20.5 M | ||
|
Apyx Medical Corporation
APYX
|
79.2 M | $ 3.97 | - | $ 137 M | ||
|
Alphatec Holdings
ATEC
|
776 M | $ 13.48 | -4.13 % | $ 1.93 B | ||
|
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | ||
|
EDAP TMS S.A.
EDAP
|
86.1 M | $ 4.08 | 0.37 % | $ 152 M | ||
|
Bio-Rad Laboratories
BIO
|
9.36 B | $ 299.07 | -2.23 % | $ 8.44 B | ||
|
Bruker Corporation
BRKR
|
5.81 B | $ 41.06 | -3.54 % | $ 6.12 K | ||
|
BioSig Technologies
BSGM
|
842 K | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
39.4 B | $ 78.26 | 3.65 % | $ 115 B | ||
|
Abbott Laboratories
ABT
|
81.4 B | $ 109.11 | 0.84 % | $ 190 B | ||
|
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | ||
|
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | ||
|
ClearPoint Neuro
CLPT
|
39.2 M | $ 12.43 | -6.61 % | $ 336 M | ||
|
CONMED Corporation
CNMD
|
2.31 B | $ 40.63 | 1.75 % | $ 1.25 B | ||
|
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | ||
|
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | ||
|
Cutera
CUTR
|
346 M | - | -10.19 % | $ 1.99 M | ||
|
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M | ||
|
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | ||
|
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
132 M | - | - | $ 10.2 M | ||
|
Electromed
ELMD
|
53.8 M | $ 28.95 | -0.96 % | $ 245 M | ||
|
InMode Ltd.
INMD
|
786 M | $ 14.77 | -1.66 % | $ 1.17 B | ||
|
GBS
GBS
|
8.25 M | - | -0.57 % | $ 7.12 M | ||
|
Second Sight Medical Products
EYES
|
41.6 M | - | -0.97 % | $ 54.4 M | ||
|
Profound Medical Corp.
PROF
|
43.9 M | $ 6.35 | -6.89 % | $ 180 M | ||
|
Align Technology
ALGN
|
6.21 B | $ 176.77 | 9.59 % | $ 13.2 B | ||
|
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | ||
|
FONAR Corporation
FONR
|
199 M | $ 18.54 | 0.11 % | $ 122 M | ||
|
Globus Medical
GMED
|
5.25 B | $ 87.55 | 0.56 % | $ 11.9 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
4.04 B | $ 10.94 | -1.26 % | $ 842 M | ||
|
Establishment Labs Holdings
ESTA
|
347 M | $ 66.7 | -3.52 % | $ 1.88 B | ||
|
IRIDEX Corporation
IRIX
|
34.4 M | $ 1.45 | 0.69 % | $ 23.4 M | ||
|
IRadimed Corporation
IRMD
|
98.3 M | $ 94.23 | 0.4 % | $ 1.19 B | ||
|
Integer Holdings Corporation
ITGR
|
3.08 B | $ 85.94 | 0.49 % | $ 2.89 B | ||
|
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | ||
|
Cytosorbents Corporation
CTSO
|
47.4 M | $ 0.67 | 0.3 % | $ 36.5 M | ||
|
OrthoPediatrics Corp.
KIDS
|
473 M | $ 16.64 | -1.54 % | $ 384 M |